Condition
Ophthalmic Surgery
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 4 (3)
Trial Status
Completed3
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07269106Phase 4RecruitingPrimary
Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery
NCT06967064Phase 4Withdrawn
The Application of Lidocaine Cream on Oral Secretions of LMA Removal During the Recovery Period in Ophthalmic Surgical Patients Under General Anesthesia
NCT05901753Not ApplicableCompletedPrimary
A Comparative Study Between Laryseal Pro Supra Glottic Device (SGD) With Proseal Laryngeal Mask Airway
NCT00350363Phase 4CompletedPrimary
One Hour Preoperative Gatifloxacin
NCT01258959CompletedPrimary
Anaesthesia for Ophthalmic Surgery: How "Retro" is the Peribulbar Block?
Showing all 5 trials